Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Regulatory T lymphocytes are associated with increased nasopharyngeal colonization in children.

Browne JJ, Matthews EH, Taylor-Robinson AW, Kyd JM.

Int J Pediatr Otorhinolaryngol. 2019 May;120:51-57. doi: 10.1016/j.ijporl.2019.02.011. Epub 2019 Feb 5.

PMID:
30771553
2.

Panel 5: Immunology.

Kyd JM, Hotomi M, Kono M, Kurabi A, Pichichero M, Ryan A, Swords WE, Thornton R.

Otolaryngol Head Neck Surg. 2017 Apr;156(4_suppl):S63-S75. doi: 10.1177/0194599816663886. Review.

PMID:
28372530
3.

Vaccination against respiratory Pseudomonas aeruginosa infection.

Grimwood K, Kyd JM, Owen SJ, Massa HM, Cripps AW.

Hum Vaccin Immunother. 2015;11(1):14-20. doi: 10.4161/hv.34296. Epub 2014 Nov 1. Review.

4.

Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.

Kunthalert D, Novotny LA, Massa HM, Ulett GC, Bakaletz LO, Kyd JM, Cripps AW.

Hum Vaccin Immunother. 2013 Mar;9(3):625-35. Epub 2013 Jan 4.

5.

Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

Moore R, Kyd JM, Carzino R, Armstrong D, Grimwood K, Otczyk DC, Cripps AW.

Hum Vaccin Immunother. 2013 Mar;9(3):506-14. Epub 2012 Dec 18.

6.

Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery.

Riedmann EM, Lubitz W, McGrath J, Kyd JM, Cripps AW.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:99-107. Epub 2011 Jan 1.

PMID:
21282975
7.

Developmental profiles of mucosal immunity in pre-school children.

Ewing P, Otczyk DC, Occhipinti S, Kyd JM, Gleeson M, Cripps AW.

Clin Dev Immunol. 2010;2010:196785. doi: 10.1155/2010/196785. Epub 2010 Dec 27.

8.

Mechanisms of bacterial resistance to antibiotics in infections of COPD patients.

Kyd JM, McGrath J, Krishnamurthy A.

Curr Drug Targets. 2011 Apr;12(4):521-30. Review.

PMID:
21194403
9.

Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.

Easton DM, Cripps AW, Foxwell AR, Kyd JM.

Front Immunol. 2011 May 16;2:13. doi: 10.3389/fimmu.2011.00013. eCollection 2011.

10.

3rd Global Vaccine Congress.

Kyd JM.

Expert Rev Vaccines. 2010 Jan;9(1):13-7. doi: 10.1586/erv.09.147.

PMID:
20021300
11.

The incidence of Streptococcus pneumoniae otitis media is affected by the polymicrobial environment particularly Moraxella catarrhalis in a mouse nasal colonisation model.

Krishnamurthy A, McGrath J, Cripps AW, Kyd JM.

Microbes Infect. 2009 Apr;11(5):545-53. doi: 10.1016/j.micinf.2009.03.001. Epub 2009 Mar 21.

PMID:
19306940
12.

Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection.

Thomas LD, Cripps AW, Kyd JM.

Vaccine. 2009 May 26;27(25-26):3324-30. doi: 10.1016/j.vaccine.2009.01.085. Epub 2009 Feb 5.

PMID:
19200832
13.

Nontypeable Haemophilus influenzae as a pathogen in children.

Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI.

Pediatr Infect Dis J. 2009 Jan;28(1):43-8. doi: 10.1097/INF.0b013e318184dba2. Review.

PMID:
19057458
14.

Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice.

Easton DM, Maier E, Benz R, Foxwell AR, Cripps AW, Kyd JM.

J Bacteriol. 2008 Dec;190(24):7994-8002. doi: 10.1128/JB.01039-08. Epub 2008 Oct 17.

15.

Functional differences between M cells and enterocytes in sampling luminal antigens.

Kyd JM, Cripps AW.

Vaccine. 2008 Nov 18;26(49):6221-4. doi: 10.1016/j.vaccine.2008.09.061. Epub 2008 Oct 11. Review.

PMID:
18852006
16.

The effect of exercise on innate mucosal immunity.

West NP, Pyne DB, Kyd JM, Renshaw GM, Fricker PA, Cripps AW.

Br J Sports Med. 2010 Mar;44(4):227-31. doi: 10.1136/bjsm.2008.046532. Epub 2008 May 22.

PMID:
18499767
17.

Optimization of oral immunization through receptor-mediated targeting of M cells.

Foxwell AR, Cripps AW, Kyd JM.

Hum Vaccin. 2007 Sep-Oct;3(5):220-3. Epub 2007 Apr 30.

PMID:
17643069
19.

Bacterial ghosts as adjuvant particles.

Riedmann EM, Kyd JM, Cripps AW, Lubitz W.

Expert Rev Vaccines. 2007 Apr;6(2):241-53. Review.

PMID:
17408373
20.

Receptor mediated targeting of M-cells.

Tyrer PC, Ruth Foxwell A, Kyd JM, Otczyk DC, Cripps AW.

Vaccine. 2007 Apr 20;25(16):3204-9. Epub 2007 Jan 17.

PMID:
17276559
21.
22.
23.

Product ion mass spectra of amphetamine-type substances, designer analogues, and ketamine using ultra-performance liquid chromatography/tandem mass spectrometry.

Apollonio LG, Whittall IR, Pianca DJ, Kyd JM, Maher WA.

Rapid Commun Mass Spectrom. 2006;20(15):2259-64.

PMID:
16810638
24.

A demonstration of the use of ultra-performance liquid chromatography-mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis.

Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):111-5. Epub 2006 Apr 17.

PMID:
16617037
25.

Enterocyte and M-cell transport of native and heat-denatured bovine beta-lactoglobulin: significance of heat denaturation.

Rytkönen J, Valkonen KH, Virtanen V, Foxwell RA, Kyd JM, Cripps AW, Karttunen TJ.

J Agric Food Chem. 2006 Feb 22;54(4):1500-7.

PMID:
16478280
26.

Microbial pattern recognition receptors mediate M-cell uptake of a gram-negative bacterium.

Tyrer P, Foxwell AR, Cripps AW, Apicella MA, Kyd JM.

Infect Immun. 2006 Jan;74(1):625-31.

27.

Impact of saliva collection methods on sIgA and cortisol assays and acceptability to participants.

Strazdins L, Meyerkort S, Brent V, D'Souza RM, Broom DH, Kyd JM.

J Immunol Methods. 2005 Dec 20;307(1-2):167-71. Epub 2005 Oct 25.

PMID:
16305798
28.

Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop.

Easton DM, Smith A, Gallego SG, Foxwell AR, Cripps AW, Kyd JM.

J Bacteriol. 2005 Sep;187(18):6528-35.

29.

Pseudomonas aeruginosa: the potential to immunise against infection.

Sedlak-Weinstein E, Cripps AW, Kyd JM, Foxwell AR.

Expert Opin Biol Ther. 2005 Jul;5(7):967-82. Review.

PMID:
16018741
30.

Vaccines for otitis media: proposals for overcoming obstacles to progress.

Murphy TF, Bakaletz LO, Kyd JM, Watson B, Klein DL.

Vaccine. 2005 Apr 15;23(21):2696-702. Review.

PMID:
15780715
31.
32.

Bacterial otitis media: a vaccine preventable disease?

Cripps AW, Otczyk DC, Kyd JM.

Vaccine. 2005 Mar 18;23(17-18):2304-10. Review.

PMID:
15755616
33.

Recent advances in otitis media. 6. Vaccine.

Giebink GS, Kurono Y, Bakaletz LO, Kyd JM, Barenkamp SJ, Murphy TF, Green B, Ogra PL, Gu XX, Patel JA, Heikkinen T, Pelton SI, Hotomi M, Karma P.

Ann Otol Rhinol Laryngol Suppl. 2005 Jan;194:86-103. Review. No abstract available.

PMID:
15700938
34.

Mucosal immunization against respiratory bacterial pathogens.

Foxwell AR, Kyd JM, Cripps AW.

Expert Rev Vaccines. 2003 Aug;2(4):551-60. Review.

PMID:
14711339
35.

Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.

Dunkley ML, Rajyaguru S, McCue A, Cripps AW, Kyd JM.

FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):37-44.

37.

Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26.

Riedmann EM, Kyd JM, Smith AM, Gomez-Gallego S, Jalava K, Cripps AW, Lubitz W.

FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):185-92.

38.

Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa.

Thomas LD, Kyd JM, Bastin DA, Dunkley ML, Cripps AW.

FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):155-60.

39.

Mucosal immunity in the lung and upper airway.

Kyd JM, Foxwell AR, Cripps AW.

Vaccine. 2001 Mar 21;19(17-19):2527-33. Review.

PMID:
11257388
40.

Programmed inflammatory processes induced by mucosal immunisation.

Foxwell AR, Kyd JM, Cripps AW.

Vaccine. 2001 Mar 21;19(17-19):2522-6. Review.

PMID:
11257387
41.

Vaccines and mucosal immunisation.

Cripps AW, Kyd JM, Foxwell AR.

Vaccine. 2001 Mar 21;19(17-19):2513-5. Review.

PMID:
11257385
42.
43.

Viral co-infection does not reduce the efficacy of vaccination against non-typeable Haemophilus influenzae middle ear infection in a rat model.

Moore R, Lidbury BA, Cripps AW, Kyd JM.

ORL J Otorhinolaryngol Relat Spec. 2001 Mar-Apr;63(2):96-101.

PMID:
11244369
44.

Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.

Thomas LD, Dunkley ML, Moore R, Reynolds S, Bastin DA, Kyd JM, Cripps AW.

Vaccine. 2000 Sep 15;19(2-3):348-57.

PMID:
10930690
45.
47.

Towards a protein vaccine for nontypeable Haemophilus influenzae.

Kyd JM, Cripps AW.

Clin Infect Dis. 1999 Feb;28(2):238. No abstract available.

PMID:
10064236
48.

Kinetics of inflammatory cytokines in the clearance of non-typeable Haemophilus influenzae from the lung.

Foxwell AR, Kyd JM, Cripps AW.

Immunol Cell Biol. 1998 Dec;76(6):556-9.

PMID:
9893034
49.

Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance.

Kyd JM, Cripps AW, Murphy TF.

J Med Microbiol. 1998 Feb;47(2):159-68.

PMID:
9879959
50.

Supplemental Content

Support Center